| Killer acquisitions C Cunningham, F Ederer, S Ma Journal of Political Economy 129 (3), 649-702, 2021 | 765 | 2021 |
| The cost of drug development: a systematic review S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson Health policy 100 (1), 4-17, 2011 | 697 | 2011 |
| Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use CM Cunningham, GE Hanley, S Morgan Health policy 97 (2-3), 122-129, 2010 | 131 | 2010 |
| Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ... Social psychiatry and psychiatric epidemiology 48, 1861-1872, 2013 | 52 | 2013 |
| Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006 S Morgan, C Cunningham Healthcare Policy 7 (1), 68-79, 2011 | 50 | 2011 |
| Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data S Morgan, G Hanley, C Cunningham, H Quan Open Medicine 5 (2), e87, 2011 | 37 | 2011 |
| The limits of relational governance: Sales force strategies in the US medical device industry AK Chatterji, CM Cunningham, JE Joseph Strategic Management Journal, 2018 | 34 | 2018 |
| Information behaviour of Canadian pharmaceutical policy makers DL Greyson, C Cunningham, S Morgan Health Information & Libraries Journal 29 (1), 16-27, 2012 | 32 | 2012 |
| Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia SG Morgan, CM Cunningham, GE Hanley PLoS One 5 (12), e15883, 2010 | 29 | 2010 |
| The British Columbia Rx Atlas S Morgan, C Cunningham, G Hanley, D Mooney University of British Columbia. Centre for Health Services and Policy Research, 2009 | 25 | 2009 |
| Income inequities in end-of-life health care spending in British Columbia, Canada: a cross-sectional analysis, 2004-2006 CM Cunningham, GE Hanley, SG Morgan International journal for equity in health 10, 1-9, 2011 | 20 | 2011 |
| Inventive capabilities in the division of innovative labor A Arora, WM Cohen, CM Cunningham National Bureau of Economic Research, 2018 | 14 | 2018 |
| Drug development: innovation or imitation deficit? SG Morgan, CM Cunningham, MR Law Bmj 345, 2012 | 14 | 2012 |
| The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia S Morgan, C Cunningham Healthcare Policy 3 (3), e128, 2008 | 14 | 2008 |
| Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study JH Puyat, GE Hanley, CM Cunningham, MR Law, ST Wong, ... Psychiatric Services, 2011 | 10 | 2011 |
| When does novelty pay? CM Cunningham Academy of Management Proceedings 2017 (1), 16957, 2017 | 9* | 2017 |
| Corporate proximity and product market reentry: The role of corporate headquarters in business unit response to product failure CM Kim, C Cunningham, J Joseph Academy of Management Journal 66 (4), 1209-1232, 2023 | 4 | 2023 |
| Listening for prescriptions: a national consultation on pharmaceutical policy issues S Morgan, CM Cunningham Healthcare Policy 6 (2), 48, 2010 | 3 | 2010 |
| Regulatory uncertainty and firm response in the US electricity industry N Dutt, CM Cunningham Academy of Management Proceedings 2015 (1), 13490, 2015 | 2 | 2015 |
| Advanced technology and creative magic: How technology use shapes the creativity-innovation process C Cunningham, H Lifshitz-Assaf, E Truelove, A Vardanyan Academy of Management Proceedings 2020 (1), 13851, 2020 | 1 | 2020 |
Steve MorganProfessor of health policy, University of British Columbia在 ubc.ca 的电子邮件经过验证
